GRI Bio, Inc.
GRI
$1.68
-$0.08-4.55%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.89M | -3.05M | -1.95M | -2.12M | -2.25M |
| Total Depreciation and Amortization | 1.00K | 1.00K | -103.00K | 1.00K | 1.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 53.00K | 231.00K | 203.00K | 47.00K | -105.00K |
| Change in Net Operating Assets | -328.00K | 1.08M | -101.00K | -194.00K | 213.00K |
| Cash from Operations | -3.17M | -1.74M | -2.00M | -2.27M | -2.14M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 5.94M | -- | 2.38M | 1.03M | 4.96M |
| Repurchase of Common Stock | 0.00 | -1.00K | 0.00 | -1.00K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -934.00K | -10.00K | -96.00K | -366.00K | -557.00K |
| Cash from Financing | 5.01M | -11.00K | 2.28M | 661.00K | 4.40M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.84M | -1.75M | 282.00K | -1.61M | 2.26M |